Canopy Immuno-Therapeutics
Canopy Immuno-Therapeutics17About
What does Canopy Immuno-Therapeutics do?
Canopy Immuno-Therapeutics is focused on developing antigen-drug conjugates (AgDCs) as a novel, non-immunosuppressive, and potentially curative therapy for antibody-mediated autoimmune diseases. Their AgDCs are designed to specifically target and eliminate pathological antibodies and autoreactive B-cells, while preserving protective immunity.
When was Canopy Immuno-Therapeutics founded?
Canopy Immuno-Therapeutics was founded in 2019.
What industry does Canopy Immuno-Therapeutics operate in?
Canopy Immuno-Therapeutics operates in Life Sciences, Immunotherapy, Immunology, Biotech, Drug Discovery, Autoimmunity.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.